EUVIMED · CrossrefJournal
Blood and Lymphatic Cancer: Targets and Therapy
ISSN 1179-9889 · Informa UK Limited
Latest articles
An Updated Indirect Comparison of Elranatamab Versus a Real-World External Control Arm in Triple-Class Refractory Multiple Myeloma
Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review
Human Immunodeficiency Virus Related Non-Hodgkin’s Lymphoma
HIV/AIDS Associated Lymphoma: Review
Clinical Value of Measurable Residual Disease in Acute Lymphoblastic Leukemia
Ruxolitinib: a targeted treatment option for patients with polycythemia vera
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
Impact of obinutuzumab alone and in combination for follicular lymphoma
Complications and management of coagulation disorders in leukemia patients
Current understanding of the role and regulation of miRNAs in Burkitt lymphoma
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives
Uptake of lymphoma-derived exosomes by peripheral blood leukocytes
Blastic plasmacytoid dendritic cell neoplasm: challenges and future prospects
Smoldering multiple myeloma: prevalence and current evidence guiding treatment decisions
Plasmablastic lymphoma: current perspectives
Advances in the diagnosis and management of lymphoma
The evaluation and optimal use of rituximab in lymphoid malignancies
Trends in the treatment of cutaneous T-cell lymphoma – critical evaluation and perspectives on vorinostat
Reduced intensity treatment in early-stage Hodgkin’s lymphoma
Emerging treatment approaches in acute lymphoblastic and acute myeloid leukemias
Outcomes and relapse patterns following chemotherapy in advanced Hodgkin lymphoma in the positron emission tomography era
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
A new era in blood and lymphatic cancer biology and therapy
Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
Mantle cell leukemia as a cause of leukostasis
Strategies for minimal residual disease detection: current perspectives
The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
IDH1-mutated relapsed or refractory AML: current challenges and future prospects
First-line therapy of chronic myeloid leukemia – focus on dasatinib
EUVIMED